Dr. Richard Bryce joins our Advisory Board
Published at 27 October 2023
We are pleased to welcome Dr. Richard Bryce, who has joined Scifiniti as a member of the Advisory Board. Dr. Bryce's experience and expertise are valuable additions to our new publishing house. We anticipate that his insights and guidance will significantly enhance our strategic decision-making processes, foster innovative approaches to scientific challenges, and contribute to the overall advancement of research within the scientific community.
Biographical Insights: Dr. Bryce is a Reader in Biomedicinal Chemistry at the University of Manchester and leads a Computational Medicinal Chemistry group in the Division of Pharmacy and Optometry. He has over 25 years of experience in biomolecular simulation, theoretical chemistry and computer-aided drug design. His awards include a Robert Lincoln MacNeil scholarship and a British Ramsay Memorial fellowship. He has authored numerous publications on methods development and applications in the area of biomolecular recognition and drug design. His work has been underpinned by productive collaborations with experimental groups, in academia locally and internationally, and within the pharmaceutical industry. He is on the editorial board for the Journal of Molecular Graphics and Modelling, an associate editor of BMC Pharmacology and Toxicology and is a previous Chair of the Molecular Graphics and Modelling Society.